Local nifedipine market seen intensifying

The domestic nifedipine market is expected to intensify this year, as some Korean companies such as Hanmi Pharm and Pacific Pharm plan to launch new formulations within the year in the hope of carving out bigger market share.

So far, Bayer's Adalat Oros has led the domestic antihypertensive market as a forerunner who developed a 24-hour sustained release dosage form of nifedipine. It annual ...